Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

Laboratory models show that the beta-blocker, propranolol, can inhibit norepinephrine-induced breast cancer cell migration. We hypothesised that breast cancer patients receiving beta-blockers for hypertension would show reduced metastasis and improved clinical outcome. Three patient subgroups were i...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Powe, Desmond G., Voss, Melanie J., Zänker, Kurt S., Habashy, Hany O., Green, Andrew R., Ellis, Ian O., Entschladen, Frank
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2010
Sujets:
Research Papers
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3248123/
https://ncbi.nlm.nih.gov/pubmed/21317458
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires